Immutep Reports Improving Results from INSIGHT-004 Trial
Date posted 22 September 2020 Release date 18 September 2020 41.7% of patients showed a Partial Response to the combination therapy of eftilagimod alpha and avelumab (previously 33%) Encouraging early anti-tumour activity signals in a variety of cancer…
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study
Date posted 22 September 2020 Release date 18 September 2020 Three complete responses (complete disappearance of all lesions) reported: two in 2nd line head and neck squamous cell carcinoma (HNSCC) and one in 1st line non-small cell lung…
Technovalia partners with the Vax4COVID Alliance and BioNet to evaluate COVIGEN
Date posted 22 September 2020 Release date 20 September 2020 Technovalia partners with the Vax4COVID Alliance and BioNet to start a Phase 1 Human Vaccine Trial in Australia with COVIGEN, a COVID-19 gene-based vaccine First SARS-CoV2 DNA vaccine…
MRFF backs COVID-19 vaccine candidate
Date posted 22 September 2020 Release date 17 September 2020 Read the full media release via Monash University. The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested almost $3 million into new COVID-19 vaccine candidates led out…
Further Investment In Three New Australian COVID-19 Vaccine Research Projects
Date posted 22 September 2020 Release date 20 September 2020 The Morrison Government will invest almost $6 million in additional funding from the Medical Research Future Fund’s (MRFF) Coronavirus Research Response to support research and development of three…
A new discovery in regenerative medicine
Date posted 22 September 2020 Release date 17 September 2020 An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.…
AdAlta and GE Healthcare collaboration progresses to next stage
Date posted 22 September 2020 Release date 20 September 2020 AdAlta Limited, a clinical stage biopharmaceutical discovery and development company using i-body technology to address challenging drug targets, is pleased to announce the extension of its collaboration with…
UniMelb tool uses fat in bone and muscle to diagnose disease, predict falls and fractures
Date posted 22 September 2020 Release date 17 September 2020 Doctors will soon be able to use fat to diagnose musculoskeletal disease within seconds and predict the risk of falls and fractures in older people, thanks to a…
Planet Innovation and Lumos Diagnostics pick up top Medical Design and Engineering Awards for rapid diagnostic development platform
15 September 2020 Planet Innovation and Lumos Diagnostics have won two awards at the 2020 Good Design Awards, including a Good Design Award Gold accolade for Lumos’s Leelu Reader. The annual Good Design Awards is Australia’s oldest and most…
Results of Cynata’s World-First Clinical Trial of iPSC-derived CYP-001 in GvHD Accepted for Publication in Nature Medicine
15 September 2020 Release date 14 September 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that a paper describing the Phase 1 clinical trial of CYP-001 in patients with graft…
Starpharma’s SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
15 September 2020 New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal, inactivating more than 99.9% of SARS-CoV-2, the virus that causes COVID-19 Potent antiviral activity of…
Opening eyes to a frontier in vision restoration
15 September 2020 Release date 14 September 2020 A world-first device to restore vision to the blind is being prepared for human clinical trials in Melbourne. Additional funding can help researchers establish an implantable device manufacturing facility to…
